Radiation-Guided Nanoparticles Zero in on Metastatic Cancer (IMAGE)

American Association for the Advancement of Science (AAAS)

Radiation-Guided Nanoparticles Zero in on Metastatic Cancer

Caption

This is a schematic illustration of selectins' role in inflammation (A) and cancer progression (B). This mechanism can be used for selectin-based targeted therapy (C). This material relates to a paper that appeared in the June 29, 2016 issue of <i>Science Translational Medicine</i>, published by AAAS. The paper, by Y. Shamay at Memorial Sloan Kettering Cancer Center in New York, NY, and colleagues was titled, "P-selectin is a nanotherapeutic delivery target in the tumor microenvironment."

Credit

Kedmi <i>et al., Science Translational Medicine</i> (2016)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.